Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Genitourinary 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 15Sezary Syndrome 13Mycosis Fungoides 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 11Leukemia, Myeloid, Acute 10Hodgkin Disease 10Myeloproliferative Disorders 9Multiple Myeloma 9Melanoma 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Hairy Cell 9Congenital Abnormalities 9Blast Crisis 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Myeloid, Accelerated Phase 8Primary Myelofibrosis 7Pdgfra-Associated Chronic Eosinophilic Leukemia 7Lymphoma 7Leukemia, Neutrophilic, Chronic 7Lymphoma, Extranodal NK-T-Cell 5Waldenstrom Macroglobulinemia 4

Interventions

pembrolizumab 36Cyclophosphamide 24Nivolumab 23Ipilimumab 22aldesleukin 19Interleukin-2 15fludarabine 14Specimen Handling 12Dacarbazine 11fludarabine phosphate 10Magnetic Resonance Spectroscopy 10Temozolomide 9Radiosurgery 9Biopsy 9cemiplimab 8Paclitaxel 8dabrafenib 5binimetinib 5Vemurafenib 5Radiotherapy 5Carboplatin 5trametinib 4sargramostim 4encorafenib 4avelumab 4Pemetrexed 4Leucovorin 4Fluorouracil 4Cisplatin 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Flow Cytometry × Dermatologic × Clear all
NCT00453050 2015-05-06

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

National Cancer Institute (NCI)

Phase 1 Completed
11 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡